← Back to Search

Behavioural Intervention

Robotic therapy for Stroke

N/A
Waitlist Available
Led By Peter G Adamczyk, Ph.D.
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects will be stroke patients with persistent moderate unilateral lower extremity deficits, age 50-85 years at time of enrollment.
Time since stroke will be greater than 6 months ("chronic" stroke survivors).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and at 5 weeks
Awards & highlights

Study Summary

This trial is testing whether a robot can help with therapy for people who have had a stroke, by measuring how well they can do different tasks before and after using the robot.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and at 5 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and at 5 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Six Minute Walk Test (6MWT) Distance
Secondary outcome measures
Change in Brain Activity in and Near Affected Areas, Through Functional MRI (fMRI)
Change in Center of Pressure (COP) Characteristics
Change in Fastest Comfortable Walking Speed (FCWS)
+2 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Robotic Training GroupExperimental Treatment1 Intervention
Robotic therapy. Subjects with Stroke who will perform the targeted training task: exercise using novel tasks on a robotic recumbent cycle.
Group II: Non-Stroke Pilot GroupExperimental Treatment2 Interventions
Robotic therapy. Aerobic therapy. Subjects without stroke, pilot subjects tested during early phases while the device and therapeutic task specifications are developed, and throughout the project while the device and tasks are refined.
Group III: Non-Stroke Comparison GroupExperimental Treatment1 Intervention
Robotic therapy. Healthy controls enrolled (age 50-85) to contribute to a normative data set on motor learning using the robotic protocols designed for stroke.
Group IV: Aerobic Training GroupActive Control1 Intervention
Aerobic therapy. Subjects with Stroke who will perform aerobic pedaling, duration-matched to the Robotic group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Robotic therapy
2020
N/A
~60

Find a Location

Who is running the clinical trial?

National Center for Advancing Translational Sciences (NCATS)NIH
316 Previous Clinical Trials
390,609 Total Patients Enrolled
6 Trials studying Stroke
682 Patients Enrolled for Stroke
University of Wisconsin, MadisonLead Sponsor
1,176 Previous Clinical Trials
3,011,962 Total Patients Enrolled
13 Trials studying Stroke
271,076 Patients Enrolled for Stroke
Peter G Adamczyk, Ph.D.Principal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
50 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Mar 2025